DNA Methylation
33
6
8
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.0%
1 terminated out of 33 trials
90.0%
+3.5% vs benchmark
3%
1 trials in Phase 3/4
0%
0 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (33)
PaCIFiC-CUP Classifies Cancer of Unknown Primary
Cervical Cytology DNA Methylation for Endometrial Lesion Screening and Follow-up
Effects Of Daily Taurine Intake For 6 Months On Biological Age and Body Metabolism Indicators As Well As Physical Fitness In 55-75-year-old Women And Men
Epigenetic Signature for CRC Early Detection
Predicting Postoperative Chemotherapy Efficacy in Patients With Esophageal Squamous Cell Carcinoma
Predicting Early Tumor Recurrence in Patients With Esophageal Squamous Cell Carcinoma
LINE-1 and Alu Methylation Levels Among Middle Aged Women With Low Cardiovascular Risk Profile in Respect of Menopausal Hot Flashes
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
Estimating Lymphocyte Counts from DNA Methylation
Cervical Cytology DNA Methylation for Cervical Cancer Screening
Comparison of the Methylation Pattern of DNA in Buccal Swabs From Different Time Points
Methylation, mIcrobiome, NUtritional sTatus, and dEvelopment of Stunted Children
First Live Birth Rate With eSET After Preimplantation Methylome Screening (PIMS) Versus Conventional In-vitro Fertilization
DNA Methylation and Cancer Prevention: Duration and Intensity of Exercise
ctDNA Methylation for Detecting Ovarian Cancer
ctDNA Methylation for Epithelial Ovarian Cancer
Epigenetic Biomarkers in the Saliva for the Diagnosis of Squamous Cells Carcinoma of the Oral Cavity
The Role of FAM19A4 and Hsa-mir-124 Methylation in Predicting Prognosis of Untreated Cervical Intraepithelial Neoplasia 2 (CIN 2)
Preimplantation DNA Methylation Test (PIMT) in ART
DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening